Keyora Skin Systems Nutrition EP-12 - Collagen Tripeptides: The Collagen Signal-to-Matrix Grand Synthesis: A Seven-Link Molecular-to-Clinical Evidence Continuum and Seven-Component Skin Nutrition Architecture

Background Skin aging and photoaging involve collagen fragmentation, altered elastic-fiber mechanics, impaired dermal water homeostasis, and epidermal barrier changes. Oral collagen preparations differ in biological source, hydrolysis, peptide-size distributions, and sequence composition; consequently, nominally equal doses cannot be assumed clinically interchangeable. Objective and Scientific Framework This final narrative synthesis integrates twelve Keyora Skin Systems Nutrition episodes through the Keyora Collagen Signal-to-Matrix Grand Synthesis. Its Seven-Link Continuum connects molecular identity, peptide composition, human exposure, cellular response, dermal extracellular matrix (ECM) homeostasis, human skin outcomes, and evidence-based nutritional selection. Five chapters extend this progression to complementary nutritional mechanisms and skin phenotype-specific interpretation. Mechanistic Foundations Collagen Gly-X-Y architecture, enzymatic hydrolysis, and sequence-resolved analysis distinguish intact Gly-Pro-Hyp (GPH) from Pro-Hyp, aggregate tripeptides, and amino acid composition. Iwai and Yamamoto documented circulating hydroxyproline-containing peptides after ingestion of defined oral preparations. In cultured human dermal fibroblasts, Ohara reported 1.5-fold greater proliferation, 2.3-fold HAS2 mRNA expression, and 3.8-fold hyaluronan synthesis following 200 nmol/mL Pro-Hyp. Chae's experimental investigations identified ECM-related gene responses involving COL1A, elastin, and fibronectin under oxidative stress. Yang's UV-photoaged mouse experiments associated Gly-Pro-Xaa-rich hydrolysates with changes in collagen, hyaluronan, elasticity, and matrix metalloproteinase-related endpoints. Human absorption, cellular responses, and animal efficacy remain distinct evidence levels. Experimental and Human Evidence Kim's randomized trial in 64 women tested 1,000 mg/day sutchi-catfish-skin collagen peptides containing over 15% tripeptides and approximately 3% GPH for twelve weeks, reporting significant improvements in selected hydration, elasticity, and wrinkle outcomes. Tak investigated 1,000 mg/day Nile-tilapia-skin tripeptides for twelve weeks and observed favorable environmentally adjusted transepidermal water loss (TEWL). Separate trials evaluated bonito elastin peptides at 100 mg/day and oral hyaluronic acid at 120 mg/day, providing ingredient-specific evidence at doses different from those in the Keyora formula. A 2025 evidence synthesis raised concerns about trial quality and funding, while a 2026 meta-analysis of 35 randomized trials found favorable pooled hydration, elasticity, and TEWL outcomes but less stable wrinkle and dermal structural findings. Integrated Scientific Interpretation Keyora's two-tablet formulation contains 1,500 mg tilapia-scale hydrolyzed collagen powder, declared 30% total tripeptides, 20 mg elastin peptides, 20 mg hyaluronic acid, 2 mg Ceramide NP, 20 mg vitamin C, 9 mg niacin equivalents as nicotinamide, and 600 micrograms biotin. Its collagen fraction corresponds nominally to approximately 450 mg aggregate tripeptides only if the percentage represents a verified mass fraction; intact GPH remains unquantified. The framework matches photoaging, wrinkles, elasticity loss, and dryness to distinct ECM, elastic-network, hydration, barrier, and metabolic research domains. Evidence Boundaries and Conclusions The Keyora Four-Object Collagen Composition Matrix and Five-Step Trust Algorithm connect analytical identity with relevant study preparations and endpoints through IDENTIFY, QUANTIFY, VERIFY, MATCH, and DECIDE. Mechanistic complementarity and trials of other formulations do not demonstrate synergy or clinical efficacy for Keyora's finished seven-component product. The Grand Synthesis establishes a testable collagen-centered research architecture rather than a clinically validated universal anti-aging intervention.